# OnCo record enspyre-mrd (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/enspyre-mrd/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "enspyre-mrd" ;
  schema:name "Enspyre"@en ;
  schema:alternateName "Biofidelity Enspyre"@en, "Enspyre" ;
  schema:description "An experimental blood test from Biofidelity in Cambridge that enriches the tumour's mutated DNA before sequencing, so it needs far less sequencing to find leftover cancer."@en ;
  schema:url <https://onco.cc/drugs/enspyre-mrd/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41598-026-57421-5> ;
  onco:status "emerging" ;
  onco:tag "test", "mrd" ;
  onco:modality "Tumour-informed ctDNA minimal residual disease assay (mutation enrichment, shallow sequencing)" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:companies <https://onco.cc/companies/biofidelity/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/tumour-informed-assay/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-labrousse-enspyre-sci-rep-2026/> .